Asian stock markets tended to weaken, amid the lack of positive sentiment coming from United States (US). This is a response to AstraZeneca vaccine.
It was recorded that only the Nikkei index in Japan and the KOSPI in South Korea (South Korea) turned into the green zone. Where the Nikkei rose 0.36% and the KOSPI rose 0.12%.
Meanwhile, the rest remained in the red zone, namely Singapore’s Straits Times Index (STI) which fell 0.23%, Hong Kong’s Hang Seng dropped 0.18% and China’s Shanghai Composite edged down 0.05%.
At the same time, Indonesia’s IHSG have strengthened 0.24% to the level of 5,773.79.
Asian market responds negatively from AstraZeneca vaccine
Asian market responds to criticism from several scientists who doubt the effectiveness of AstraZeneca vaccine in collaboration with the University of Oxford. Previously, this vaccine was 90% more effective.
This scientist’s latest view is not without reason. The reason is, at the beginning, there were some mistakes. It started when a small group of volunteers received a lower dose of the vaccine accidentally. The result was the vaccine was successful 90%.
But in the larger group with the normal dose, the success rate was even lower, only 62%. Many scientists have interpreted testing in small groups as ‘yielding false readings’.
“All you have to do is release limited data,” said Peter Openhaw, professor of experimental medicine at Imperial College London, quoting from Reuters on Friday (27/11/2020).
“We have to wait for the complete data and to see how regulators see the results.”
Thus, it raised the concerns of the Head of Operation Warp Speed. He is one of special team for handling President Donald Trump’s corona, Moncef Slaoui. Moreover, he said that people who have lower risk showed 90% efficacy. It is as many as 2,741 people under 55%.
AstraZeneca CEO’s response
AstraZeneca CEO Pascal Soriot said the British pharmaceutical giant was likely to run additional global trials to evaluate the vaccine’s efficacy, as quoted by Bloomberg.
An AstraZeneca spokesman also rejected the scientist’s criticism. The company admits that the test is in accordance with the Data Safety Monitoring Board (DSMB) standard.
Meanwhile, data on China’s industrial profits for the period of October 2020 recorded positive growth to the level of 0.7% and away from the previous negative level, namely 2.4%.